Cardiome Pharma Corp. (CRME) Profile

Profile for Cardiome Pharma Corp.  (CRME) 
$ 2.41   -0.14 (-5.49%) Volume: 126.05 k 4:00 PM EST Feb 10, 2012
Business Description:
Cardiome Pharma Corp. is a life sciences company which is focused on developing drugs to treat or prevent cardiovascular diseases.
Address: 6th Floor, 6190 Agronomy Road, Vancouver, BC, CA, V6T 1Z3
Telephone: (604) 677-6905 Website: www.cardiome.com
Facsimile: (604) 822-9578 Email: ir@cardiome.com
Details
CEO: Douglas G. Janzen
Employees: 79 Market Cap: 147.32 m
Issue Type: CS
Auditor: KPMG LLP
Last Audit: Unqualified
Indices: Drug Manufacturers - Other
Industry Classifications
Sector: Healthcare CIK: 0001036141
Industry: Drugs
Sub-Industry:    Drug Manufacturers - Other
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)   

Tags for Cardiome Pharma Corp.

Research stocks or mutual funds related to Cardiome Pharma Corp. by keywords or tags. Find companies that have a similar focus to CRME. The keywords below have been associated to CRME by either user submission or electronic means.

stock trading png pipeline real time stock quote stock investments africa stock ups stock quote online stock quote stock recommendations stock analyst research atrial fibrillation hong kong stock quote live stock quote cnn stock market report india stock quotes financial annual report msft stock quote pfizer stock quote annual report stock market ticker stock investment japan stock quotes stock markets historical stock market data otcbb stock stock quote stock market reports pharmaceutical clinical research stock news analysis amzn stock quote training broker stock stock music financial report stock quote chart stock report annual report printing investor relations data xom stock quote at&t stock quote toronto stock exchange nyse stock quote real time streaming stock quotes pharmaceutical sales stock market quotes oil pipeline historical stock charts biotech corporation stock market software stock quote software employee stock nyse stock prices